This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,448.32 contract is for the delivery of 1,000 unit vials of the specialized pharmaceutical product Kcentra.
The contract is not associated with any set-aside designation and has an ultimate completion date of January 14, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides the DLA with branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.
Generated 3/21/25, 10:02 AM